PACE, ANGELICA
 Distribuzione geografica
Continente #
AS - Asia 880
EU - Europa 765
NA - Nord America 520
SA - Sud America 175
AF - Africa 44
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.396
Nazione #
US - Stati Uniti d'America 484
IT - Italia 467
SG - Singapore 349
CN - Cina 210
BR - Brasile 136
HK - Hong Kong 116
DE - Germania 74
FI - Finlandia 47
VN - Vietnam 44
IN - India 42
KR - Corea 41
NL - Olanda 23
AR - Argentina 22
MA - Marocco 21
FR - Francia 20
CA - Canada 19
AT - Austria 18
GB - Regno Unito 18
RU - Federazione Russa 18
SE - Svezia 17
CH - Svizzera 14
BD - Bangladesh 11
JP - Giappone 11
AU - Australia 10
CI - Costa d'Avorio 10
MX - Messico 10
PL - Polonia 10
IQ - Iraq 9
BG - Bulgaria 8
ID - Indonesia 8
TR - Turchia 8
ZA - Sudafrica 8
ES - Italia 7
EC - Ecuador 6
IE - Irlanda 5
PK - Pakistan 5
BE - Belgio 3
CO - Colombia 3
CZ - Repubblica Ceca 3
IL - Israele 3
IR - Iran 3
PH - Filippine 3
TH - Thailandia 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CL - Cile 2
EG - Egitto 2
JM - Giamaica 2
LT - Lituania 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
UA - Ucraina 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BH - Bahrain 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PR - Porto Rico 1
RO - Romania 1
TZ - Tanzania 1
Totale 2.396
Città #
Singapore 238
Rome 227
Hong Kong 107
Ashburn 90
Dallas 67
Hillsboro 29
Beijing 28
Helsinki 28
Los Angeles 28
Munich 28
New York 20
Milan 19
Santa Clara 19
Casablanca 17
Ho Chi Minh City 17
Nuremberg 16
Cosenza 15
Perugia 14
Buffalo 13
Seoul 13
Turku 13
Salt Lake City 12
Shanghai 12
Council Bluffs 11
Naples 11
São Paulo 11
Abidjan 10
Palermo 10
Hefei 9
Redondo Beach 9
Hyderabad 8
Indore 8
Sofia 8
Wroclaw 8
Albano Laziale 7
Brooklyn 7
Frankfurt am Main 7
Guangzhou 7
Lugano 7
Tianjin 7
Tokyo 7
Vienna 7
Chicago 6
Falkenstein 6
Hanoi 6
Lappeenranta 6
Montreal 6
Bengaluru 5
Boardman 5
Dublin 5
Hangzhou 5
Jakarta 5
Jena 5
Melbourne 5
Pomezia 5
San Isidro 5
Arezzo 4
Baltimore 4
Florence 4
Goyang-si 4
Johannesburg 4
London 4
Philadelphia 4
Renens 4
Seattle 4
Seodaemun-gu 4
Wuhan 4
Aachen 3
Bangkok 3
Basra 3
Brussels 3
Campinas 3
Changsha 3
Cologne 3
Da Nang 3
Dongjak-gu 3
East Brunswick 3
Germiston 3
Hengyang 3
Houston 3
Istanbul 3
Jiaxing 3
Kolkata 3
Magog 3
Mapo-gu 3
Modena 3
Monte Grande 3
Moscow 3
Mumbai 3
Olomouc 3
Ottawa 3
Quito 3
Rancho Palos Verdes 3
Rimini 3
Salerno 3
San Jose 3
Seocho-gu 3
Somerville 3
Taipei 3
Toronto 3
Totale 1.447
Nome #
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma 266
ASGR2 AND CLEC12A C TYPE LECTINS: NEW PLAYERS IN GLIOBLASTOMA IMMUNOSUPPRESSIVE NETWORKS 159
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 138
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 136
Soluble immune biomarkers to predict clinical outcome in head and neck patients treated with immunotherapy 115
MGL lectin receptor and immunosuppression networks in glioblastoma 106
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 105
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 102
Novel circulating biomarkers in HNSCC patients receiving anti-PD1 therapy: the predictive and prognostic role of immunosuppressive CD137+Treg cells and Lox-1+PMN-MDSCs 92
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma 92
Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment 91
Treg/CD137+ T cell balance as a novel biomarker of survival in advanced non-addicted NSCLC patients treated with immunotherapy as first-line 90
Immunological network signature of naïve non-oncogene-addicted non-small cell lung cancer patients treated with anti-PD1 therapy. A pilot study 89
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients 88
Network analysis to unveil lectins-mediated immunosuppression in glioblastoma 84
Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients 83
Immunogenic cell death and immunomodulatory effects of cabozantinib 79
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs 76
Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation 75
Network analysis to dissect glioblastoma immunosuppression complexity: identification of C-type lectins as potential therapeutic candidates and biomarkers 73
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: systematic review and meta-analysis 72
Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients 71
Woman in General and Clinical Pathology 55
Novel C-type lectins profile as immunosuppression players and potential biomarkers in cancer patients 45
null 25
null 22
Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients 14
Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients 13
null 9
Age-related immunological alterations influence resistance to anti-PD1-based therapies in elderly NSCLC patients 9
Totale 2.474
Categoria #
all - tutte 7.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 5 4 2 0 2 0 0 8 11
2022/202375 7 4 4 6 6 4 3 4 2 10 8 17
2023/2024318 7 19 10 18 47 72 16 15 3 28 49 34
2024/20251.066 71 51 66 43 75 72 96 80 124 75 146 167
2025/2026983 198 210 194 183 198 0 0 0 0 0 0 0
Totale 2.474